Development of a Decision-Analytic Model of Stroke Care in the United States and Europe
- 1 March 2002
- journal article
- Published by Elsevier in Value in Health
- Vol. 5 (2) , 82-97
- https://doi.org/10.1046/j.1524-4733.2002.52011.x
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Performing Cost-Effectiveness Analysis by Integrating Randomized Trial Data with a Comprehensive Decision ModelJournal of Clinical Epidemiology, 1999
- The Burden of Caregiving in Partners of Long-Term Stroke SurvivorsStroke, 1998
- Stroke-attributable nursing home useNeurology, 1998
- Cost-effectiveness of tissue plasminogen activator for acute ischemic strokeNeurology, 1998
- The Stroke Prevention Policy Model: Linking Evidence and Clinical DecisionsAnnals of Internal Medicine, 1997
- Costs of Medical Care After First-Ever Stroke in the NetherlandsStroke, 1995
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994
- Markov Models in Medical Decision MakingMedical Decision Making, 1993
- The Cost of Stroke to the National Health Service in ScotlandCerebrovascular Diseases, 1992
- Disability and use of rehabilitation services following stroke in Rochester, Minnesota, 1975-1979.Stroke, 1987